Literature DB >> 12167235

Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo.

Richard T Kershen1, James J Yoo, Robert B Moreland, Robert J Krane, Anthony Atala.   

Abstract

A large number of congenital and acquired abnormalities of the genitalia would benefit from the availability of transplantable, autologous corpus cavernosum tissue for use in reconstructive procedures. We describe the results of preliminary experiments designed to determine the feasibility of using cultured human corporal smooth muscle cells seeded onto biodegradable polymer scaffolds for the formation of corpus cavernosum smooth muscle in vitro and in vivo. Primary cultures of human corpus cavernosum smooth muscle cells were derived from operative biopsies obtained during penile prosthesis implantation. Cells were characterized in vitro and seeded as a contiguous multilayered sheet onto polymers of non-woven polyglycolic acid. The seeded polymer constructs were then implanted subcutaneously in athymic mice. Animals were killed 7, 14, and 24 days after surgery and implants were examined via histology, immunocytochemistry, and Western blot analyses. Cultured cell multilayers were identified as smooth muscle before implantation via phase-contrast microscopy, immunocytochemistry and Western blot analyses. Retrieved implants from all time points demonstrated corporal smooth muscle tissue grossly, and histologically, at the time of sacrifice. Intact smooth muscle cell multilayers were observed growing along the surface of the polymers. There was evidence of early vascular ingrowth at the periphery of the implants by 7 days. By 24 days, there was evidence of polymer degradation. Maintenance of the smooth muscle phenotype in vivo was confirmed immunocytochemically and by Western blot analyses with antibodies to alpha-smooth muscle actin. This study provides evidence that cultured human corporal smooth muscle cells may be used in conjunction with biodegradable polymer scaffolds to create corpus cavernosum smooth muscle tissue in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167235     DOI: 10.1089/107632702760184754

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  18 in total

1.  A new method of measuring the stiffness of corpus cavernosum penis with ShearWave™ Elastography.

Authors:  J-J Zhang; X-H Qiao; F Gao; F Li; M Bai; H-P Zhang; Y Liu; L-F Du; J-F Xing
Journal:  Br J Radiol       Date:  2015-02-17       Impact factor: 3.039

Review 2.  New advances in erectile technology.

Authors:  Marshall J Stein; Haocheng Lin; Run Wang
Journal:  Ther Adv Urol       Date:  2014-02

Review 3.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

4.  In vivo human corpus cavernosum regeneration: fabrication of tissue-engineered corpus cavernosum in rat using the body as a natural bioreactor.

Authors:  Abdol-Mohammad Kajbafzadeh; Reza Abbasioun; Nastaran Sabetkish; Shabnam Sabetkish; Ali Akbar Habibi; Kamyar Tavakkolitabassi
Journal:  Int Urol Nephrol       Date:  2017-04-05       Impact factor: 2.370

5.  An experimental study: evaluating the tissue structure of penis with 2D-ShearWave™ Elastography.

Authors:  X-H Qiao; J-J Zhang; F Gao; F Li; Y Liu; L-X Xing; L-F Du; J-F Xing
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

Review 6.  Erectile dysfunction following prostatectomy: prevention and treatment.

Authors:  Ahmed Magheli; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

Review 7.  Looking to the future for erectile dysfunction therapies.

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Bioengineered corporal tissue for structural and functional restoration of the penis.

Authors:  Kuo-Liang Chen; Daniel Eberli; James J Yoo; Anthony Atala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

Review 9.  Tissue engineering in urology: where are we going?

Authors:  Adam R Metwalli; James R Colvert; Bradley P Kropp
Journal:  Curr Urol Rep       Date:  2003-04       Impact factor: 2.862

Review 10.  Future prospects in the treatment of erectile dysfunction: focus on avanafil.

Authors:  Amjad Alwaal; Raed Al-Mannie; Serge Carrier
Journal:  Drug Des Devel Ther       Date:  2011-10-18       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.